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The Influence of the MAPK Pathway
on T Cell Lineage Commitment
indicates that the Ras-to-MAPK (mitogen-activated pro-
tein kinases or extracellular signal-related kinases
[ERKs]) pathway is critically involved (Alberola-Ila et al.,
Leslie L. Sharp,* David A. Schwarz,*
Cynthia M. Bott,² Christopher J. Marshall,²
and Stephen M. Hedrick*³
1996; Crompton et al., 1996; Swat et al., 1996).*The Department of Biology and the Cancer Center
A further aspect of this fate decision is that the cellsUniversity of California, San Diego
differentiate into either CD4 or CD8 T cells dependingLa Jolla, California 92093±0687
on the TCR specificity for either MHC class II or class²Section of Cell and Molecular Biology
I molecules. Two possibilities have been suggested toInstitute of Cancer Research
explain the coordination of phenotype with MHC recog-Chester Beatty Laboratories
nition (Chan et al., 1994a; Davis and Littman, 1994; Ro-London SW36JB
bey and Fowlkes, 1994). One is ªinstructional.º That is,United Kingdom
the recognition of a particular class of MHC molecules
instructs the DPs to differentiate. How the signals from
MHC class I and class II differ is unspecified, but recentSummary
experiments provide evidence for a quantitative instruc-
tional model (Itano et al., 1996; Matechak et al., 1996).During development, progenitor thymocytes differen-
The notion is that a relatively strong signal, usually ac-tiate into either CD4 or CD8 T cells, and this fate deci-
companied by CD4±MHC class II interactions, instructssion depends on the specificity of the T cell antigen
DP thymocytes to differentiate into CD41CD82 (CD4receptor (TCR) for MHC class II or class I molecules.
single-positive [CD4SP]) T cellsand that a weaker signal,Based on the mechanisms of fate specification known
usually accompanied by CD8±MHC class I interactions,for simple metazoan organisms, we sought to deter-
results in CD42CD81 (CD8SP) T cells. Support for thismine whether the extracellular signal-related kinases
mechanism comes from experiments that relied on the(ERKs) play a role in T cell differentiation and lineage
deletion or modification of coreceptors to provide morecommitment. Using a dominant gain-of-function mu-
or less signaling to the DP thymocytes. A second class oftant of the erk2 gene, we show that differentiation
models invoked to explain CD4 versus CD8 phenotypicinto the CD4 lineage is favored. We also show that,
differentiation have been termed ªstochastic-selectiveºconversely, the addition of a pharmacological inhibitor
(Davis et al., 1993; Chan et al., 1994b). The notion is thatof the ERK pathway favors differentiation into the CD8
DP thymocytes, which receive a signal through the TCR,lineage. Wepresent aquantitative selection model that
randomly (stochastically) begin to differentiate into aincorporates these results as well as those of recent
CD4 or a CD8 T cell. A consequence of this is that onereports on the role of Notch in T cell lineage specifi-
of the two coreceptors is down-regulated, and thymiccation.
maturation is completed only if the stochastic decision
is consistent with the specificity of the TCR for either
MHC class I or class II molecules.Introduction
Ultimately, an understanding of lineage commitment
will depend upon establishing the receptor-mediatedThere are two major steps in T cell development. The
signaling pathways that alter nuclear transcription. To-first is initiated by the rearrangement of the T cell antigen
ward that end, recent work has shown that the cell sur-receptor (TCR) b-chain and the expression of the pre-T
face receptor Notch may influence CD4 versus CD8cell receptor (Godfrey et al., 1993; Groettrup et al., 1993;
lineage decisions in a manner similar to the way it deter-Dudley et al., 1994; Hoffman et al., 1996). This event
mines primary versus secondary cell fate of Drosophilaprovokes the cells to enter thecell cycle and differentiate
melanogaster peripheral neurogenesis and Caenorhab-from CD42CD82, double-negative (DN) thymocytes, into
ditis elegans vulval fate differentiation (Robey et al.,CD41CD81, double-positive (DP) thymocytes. The sec-
1996). Although a mechanism of activation and a linearond step involves selection mediated by the TCR (re-
signaling pathway are known for the imaginal discviewed by Robey and Fowlkes, 1994; Kisielow and von
proneural clusters (Bailey and Posakony, 1995), theBoehmer, 1995). Subsequent to a productive TCR a-chain
equivalent signaling cascade has not been establishedrearrangement, the DPs undergo either apoptosis or
for mammalian Notch. Furthermore, it is not known, in
differentiation into mature T cells; there is evidence that
any organism, how Notch signaling is related to the
the outcome is decided by the recognition of a specific
MAPK cascade.
peptide bound to major histocompatibility (MHC) mole-
A powerful tool in the establishment of signaling cas-
cules, and the difference is in the avidity or affinity of
cades important in development is the screen for hyper-
the interaction (Jameson et al., 1995). The intracellular
morphic gain-of-function mutations that suppress a ge-
signaling that specifies expansion, differentiation, and
netic deficiency. Although the size of the genome and
positive versus negative selection is poorly understood,
the generation time is such that we cannot readily carry
but, depending on the experimental approach, evidence
out this sort of analysis in mice, we can take advantage
of mutants isolated in flies and worms to understand
the way a signaling network affects a mammalian devel-³To whom correspondence should be addressed (e-mail: shedrick
@ucsd.edu). opmental system. Using the mammalian equivalent of
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a gain-of-function mutation inDrosophila erk-A, we have
established a role for ERK2 in the CD4 versus CD8 lin-
eage decision in T cell development. We then supported
the conclusions from these experiments by conducting
further studies using a pharmacological agent to inter-
rupt the activation of ERK.
Results
The Production of Transgenic Mice Expressing
a Hypersensitive Form of ERK2
To study the role of ERK2 in thymocyte development,
we expressed a hypersensitive form of ERK2 based on
the Drosophila mutant sevenmaker (rlsem) in transgenic
mice. This mutant was isolated by a genetic screen for
a dominant suppressor of bride of sevenless (boss), and
it was found to arise from an aspartate-to-asparagine
substitution at amino acid 334 in ERKA (Brunner et al.,
1994). In addition to activating the sevenless pathway,
leading to the formation of the R7 cells in the retina, rlsem
was found to activate the torso (tor) pathway, and it
affects some, but not all developmental pathways medi-
ated by theDrosophila homolog of the epidermal growth
factor (EGF) receptor, DER. A mouse ERK2 homolog
was produced by substituting an aspartate at 319 with Figure 1. ERK2sem Is Expressed and Can be Activated in Lympho-
an asparagine (referred to here as ERK2sem), and it was cytes
shown to manifest a hypersensitivity due to delayed (A) Representation of the pTEX-SM targeting construct used in the
dephosphorylation (Bott et al., 1994; Ward et al., 1994). generation of ERKsem (SM) transgenic mice (see Experimental Proce-
dures).The baseline activity is equivalent to wild type, and so
(B) Cells (5 3 106) from the indicated organs were incubated at 378Cthis is not a constitutively active but rather a hypersensi-
for 10 min in the presence or absence of 5 ng/mL PMA. The cellstive form of ERK2.
were then lysed and immunoblotted using anti-ERK2 (C-14). LN,
The Myc-tagged mouse ERK2sem was cloned into the lymph node; NLC, normal littermate control.
pTEX expression vector, based on the human CD2 pro- (C) Thymocytes were stimulated with 5 ng/mL PMA in Hank's bal-
moter/enhancer/locus control region (Lake et al., 1990; anced salt solution at 378C for the indicated times. Whole-cell lysate
(20 mg) was immunoblotted with anti-phospho-MAPK.Zhumabekov et al., 1995), and the transcriptional cas-
sette was used to produce transgenic mice (Figure 1A).
Six lines of transgenic mice were produced, leading to
10 independent lines because of multiple incorpora- ERK2 was also detected,although the the phosphorylated
and unphosphorylated forms did not entirely resolvetions. Using a probe from the human CD2 vector, five
lines expressed detectable message in the thymus by (see also below, Figure 5). Compared with wild-type
ERK2, a greater proportion of ERK2sem was phosphory-Northern blots. Of these, three expressed detectable
levels of ERK2sem using an ERK2-specific polyclonal anti- lated.
Using an antibody specific for phospho-ERK, we fur-sera (C-14). The line expressing the highest level of
ERKsem protein, sem20, had approximately 10 copies of ther tested the time course of ERK2 activation.As shown
in Figure 1C, treatment of thymocytes with 10 ng/ml ofthe transgene, as estimated by Southern blotting, and
was bred for analysis. PMA caused the appearance of phospho-ERK2 within
5 min. This form of ERK2 was detected for at least 30ERK2 could be detected as a 42 kDa protein on West-
ern blots from thymus and lymph node cells (Figure 1B). min and was essentially undetectable after 60 min. Using
thymocytes from sem20 mice, there was a very similarSince ERK2sem contained a Myc tag in our experiments,
it ran with slightly reduced mobility on SDS±polyacryl- time course of ERK2 appearance; however, there was
a substantial increase in the levels of phospho-ERK2.amide gel electrophoresis (PAGE), as seen in the thymus
and lymph nodes from sem20 mice. We estimate that It appeared that both endogenous and ERKsem were
phosphorylated to higher levels, even though extractsthe transgene was expressed at a level no greater than
20% of endogenous ERK2. were adjusted to 20 mg protein/well. We note that no
background phospho-ERK2 was detectable in the ab-Activation with phorbol myristic acid (PMA) is known
to stimulate phosphorylation of ERK2 through Raf-1 sence of PMA.
These data indicate that the transgenic ERK2sem is(Kolch et al., 1993; Marquardt et al., 1994; Qiu and Leslie,
1994), and this is revealed by the decreased mobility of hypersensitive, though expressed and activated in
manner very similar to that of endogenous ERK2. Al-phospho-ERK. In thymus and lymph node cells from
sem20 mice treated with PMA, there was an easily de- though previous data indicated that dephosphorylation
of ERKsem was delayed compared to controls (Bott ettectable phosphorylated form of ERK2sem (Figure 1B).
A lower-mobility phosphorylated form of the wild-type al., 1994; Ward et al., 1994), the difference is probably
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data confirms the results shown in Figure 2; the percent-
age of CD4SP thymocytes was significantly greater in
sem20 mice compared with littermates, to a highly sig-
nificant level by Student's t test (P , 0.0001). The differ-
ence in CD8 T cells in the lymph nodes also was highly
significant (P , 0.0005). Thus, the expression of ERKsem
caused an alteration in the proportion of cells in the CD4
and CD8 lineages, although in adult mice, the increased
proportion of CD4SP thymocytes is reflected in a de-
creased proportion of CD8 lymph node T cells.
We also wished to determine how the expression of
ERK2sem would affect the development of T cells in fetal
thymic organ cultures (FTOCs). In young adult mice the
populations reflect a steady state that is subject to ho-
meostatic feedback mechanisms (Berg et al., 1989), and
a high rate of apoptosis and engulfment (Surh andFigure 2. ERKsem Alters Thymus and Lymph Node Subsets
Sprent, 1994). On the other hand, in FTOCs the subsetsCells from sem20 (SM) or normal littermate control (NLC) mice were
stained with anti-CD4-PE and anti-CD8-Tricolor. Numbers represent represent a wave of maturation, which to some extent
the percentage of live cells in the indicated quadrant. Ten thousand reflects the rate of development. As shown in Figure 2,
events are shown. E16 FTOC, cells after 5 days of culture starting 5-day FTOCs from embryonic day 16 (E16) sem20 mice
at embryonic day 16.
showed skewing of thymocyte populations, such that
there was a consistent increase in the proportion of
too subtle to detect based on the time points measured. CD4SP cells and a decrease in the proportion of CD8SPs
Kinase assays were not carried out since the Myc tag compared to normal littermate controls. In the E16
prevents immunoprecipitation with anti-ERK2 antibody. FTOCs, the number of cells and the percentage in each
We therefore could not directly compare the kinase ac- subset were variable from experiment to experiment.
tivity of the transgenic ERK2sem with endogenous ERK2; However, the ratio of CD4SP to CD8SP cells was reveal-
however, PMA-mediated phosphorylation of ERK2 cor- ing: we found that the ratio of CD4SP to CD8SP for
relates well with activity (Marquardt et al., 1994). sem20 mice was 2.3 6 0.38 (n 5 6) and that for wild-
type mice it was 1.6 6 0.37 (n 5 5) (P , 0.02).
The Expression of ERKsem Alters To examine the effect of ERKsem on negative selection,
T Cell Development we examined superantigen-mediated deletion of SP thy-
To investigate the role of ERK2 in thymic development, mocytes and lymph node T cells. The percentage of SP
we examined the proportion and absolute numbers of thymocytes and lymph node T cells that expressed Vb11
cells in each of the thymic subsets characterized by the is a measure of the deletion mediated by MMTV-8, 9,
expression of CD4 and CD8. An exemplary experiment 17 (Scherer et al., 1993), whereas total Vb8-bearing T
is depicted in Figure 2. Compared to normal littermate cells are not altered by any of the MMTV proviruses in
controls, there was an increased proportion of CD41CD82 the strains tested. As shown, there was no difference
thymocytes (CD4SP) and a coordinate decrease in the in MMTV-mediated deletion of Vb11-bearing T cells (Ta-
percentage of CD41CD81 (DP) thymocytes. The per- ble 1). This outcome agrees with the work of Perlmutter
centages of CD42CD82 (DN) and CD42CD81 (CD8SP) and his colleagues in that the MAPK pathway affects
thymocytes were essentially unchanged, and there were positive but not negative selection (Alberola-Ila et al.,
no changes in the CD3 profiles in any of the subsets. 1995, 1996; Swan et al., 1995).
The lymph node T cells showed a different effect: the
percentage of CD4 T cells was unchanged, whereas the
percentage of CD8 T cells was, on average, 67% of The Effects of ERK2sem on T Cell Development
in the Presence of a Class II±Specificnormal (Table 1).
The total cellularity of the thymi in sem20 mice was Transgenic TCR
Since ERKsem activity is inducible, presumably it will de-an average of 68% that of littermate controls, although
there was no change in the total number of cells residing pend on signal transduction originating from ligation of
the TCR (Izquierdo et al., 1993). Therefore we sought toin the pooled inguinal, brachial, mesenteric, and sub-
maxillary lymph nodes (Table 1). A compilation of the examine the development of T cells in TCR transgenic
Table 1. Lymphocyte Subpopulations in sevenmaker Transgenic Mice
No. of Cells
(3 107) % CD4 % CD8 % Vb8 SP % Vb11 SP
Thymus NLC 9.5 6 4.2 10.7 6 1.4 3.1 6 0.8 16.0 6 0.6 2.1 6 0.3
SM 6.5 6 2.6 14.0 6 2.3 3.3 6 1.0 16.4 6 1.0 2.2 6 0.2
Lymph node NLC 2.7 6 0.9 38.9 6 4.1 25.0 6 5.8 19.3 6 0.4 2.6 6 0.6
SM 2.5 6 0.9 38.8 6 4.5 16.9 6 3.3 19.4 6 0.6 2.4 6 0.4
Data are represented as means 6 standard deviation. NLC, n 5 16; SM, n 5 18.
Underlining indicates SM values significantly different (Student's T test, P , 0.0005) from NLC.
Immunity
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population in the AND 3 sem20-H-2b mice is that the
DP population is small.
Interruption of the MAPK Pathway
To investigate further the role of ERK in T cell develop-
ment we took advantage of a newly discovered com-
pound, PD98059, from Parke Davis (Alessi et al., 1995;
Dudley et al., 1995). This compound has been shown
to inhibit the phosphorylation of MEK1 and MEK2 by
upstream activators such as c-Raf and thus far appears
to be highly selective. To determine the dose-response
characteristics in lymphocyte cultures, we first titrated
Figure 3. Alteration of Thymic Subsets in AND 3 sem20 (AND 3 PD98059 into anti-CD3±stimulated CD41 lymph node T
SM) Double-Transgenic Mice Is MHC Haplotype±Dependent
cell cultures from sem20 or littermates. As depicted in
Thymocytes were triple stained with anti-CD4-PE, anti-CD8-Tri- Figure 4A, PD98059 inhibited the proliferative responsecolor, and anti-CD3-FITC. Numbers represent the percentage of
of both populations to about 14% of the maximum at acells in the indicated quadrant. Ten thousand events are shown.
concentration of 25 mM. This concentration of PD98059Dashed lines, AND normal littermate control; solid lines, AND 3 SM.
was also effective in antigen-stimulated cultures. Lymph
node T cells from ANDmice were stimulatedwith varying
amounts of PCC 88±104 peptide in the presence andmice in which we could manipulate receptor recognition.
absence of 25 mM of PD98059. As shown, PD98059The AND strain of mice has a transgenic TCR that is
shifted the dose-response curve by almost 100-fold tospecific for pigeon cytochrome c (PCC) 88±104. sem20
higher concentrations of added peptide antigen (Figuremice were crossed with AND mice and bred to express
4B). This result shows that MEK activation is essentialdifferent MHC molecules that do or do not support posi-
for antigen-induced T cell proliferation. This finding istive selection: H-2b (Ab-E8) and H-2d (Ad-Ed).
not consistent with the observation that a catalyticallyIn theAND-H-2d nonselectingmice, ERKsem had essen-
inactive form of MEK1 does not inhibit T cell proliferationtially no effect on the subsets of thymocytes. The 10%
(Alberola-Ila et al., 1995).CD4 population resulted from dual expression of trans-
To demonstrate the effectiveness of PD98059 ingenic and endogenous TCR a-chains, according to flow
blocking the activation of MEK and ERK, we first exam-cytometry analysis (data not shown) and the observation
ined a proliferative response induced by the additionthat AND-H-2dRag-22/2 mice have virtually no CD4SP
of PMA. A result that we did not anticipate was thatthymocytes (Lerner et al., 1996). In contrast, in the pres-
thymocytes from sem20 but not wild-type mice prolifer-ence of TCR recognition associated with positive selec-
ated with the addition of PMA alone. Since wild-typetion, there was a significant effect. Compared to AND-H-
lymphocytes usually requirean additional stimulus, such2b mice, in double-transgenic AND 3 sem20-H-2b mice
as an increase in cytoplasmic calcium, this finding indi-there was a significant drop in thymus cellularity, a de-
cates that proliferation of thymocytes can be mediatedcrease in the proportion of DPs, and an increase in the
by ERK activation above the level that can be achievedproportion of CD4s. The small population of CD8SPs
by PMA stimulation in wild-type cells (Figure 5A). Thiswas unchanged (Figure 3 and Table 2).
proliferation was effectively inhibited by the addition ofThis finding reinforces the notion that the transgenic
17.5 mM PD98059. Since PMA has been shown to acti-ERK2sem influences the outcome of thymic development
vate Raf21 indirectly through protein kinase C (Kolchin response to TCR-mediated interactions. The CD3 ex-
et al., 1993) and since cells transgenic for ERKsem, butpression profiles reflect the thymus subsets, in that DP
not wild-type cells, were activated, the inhibition bythymocytes express an intermediate level of CD3 and
PD98059, as an inhibitor of MEK activation, is consistentSP thymocytes express it at a high level. The DN cells
with the canonical MAPK phosphorylation cascade ofare composed of immature and mature thymocytes, and
Raf-1→MEK→ERK (Howe et al., 1992; Kyriakis et al.,at least the mature DN thymocytes generally express
1992; Marshall, 1994). As a way of showing that thehigh levels of CD3 in TCR transgenic mice. The reason
that there appears to be no distinct CD3-intermediate MEK inhibitor is effective in blocking ERK2 activation,
Table 2. Thymocyte Subpopulations in AND 3 SM TCR Transgenic Mice
No. of Cells
MHC Haplotype (3 107) % DP % CD4 % CD8
H-2d AND 2.3 6 0.3 56.7 6 8.6 11.4 6 1.4 5.8 6 2.1
AND 3 SM 2.4 6 1.5 60.2 6 3.2 10.4 6 0.9 4.5 6 1.7
H-2b AND 8.2 6 4.0 35.5 6 7.7 54.6 6 8.7 1.3 6 0.4
AND 3 SM 3.1 6 1.6 17.6 6 3.4 66.2 6 2.9 1.7 6 0.7
Data are represented as means 6 standard deviation. AND-H-2d, n 5 3; AND 3 SM-H-2d, n 5 4; AND-H-2b, n 5 13, AND 3 SM-H-2b, n 5 13.
Underlining indicates AND 3 SM values significantly different (Student's T test, P , 0.005) from AND controls.
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Figure 4. MEK Activation Is Required for TCR and Peptide-Medi-
ated Proliferation
(A) Lymph node cells from a sem20 (SM) mouse (filled squares) or
a normal littermate control (open squares) mouse were stimulated
with 10 ng/well 145±2C11 (anti-CD3) and the indicated concentration
of PD98059 MEK Inhibitor. Proliferation after 3 days was determined
by the incorportion of 1 mCi of [3H]thymidine.
(B) AND-H-2b lymph node cells were cultured with mitomycin
C±treated B10.A splenic antigen-presenting cells and the indicated
concentrations of PCC peptide in the presence (open squares) or
absence (filled squares) of 25 mM PD98059. Figure 5. MEK Inhibitor Blocks Thymocyte Proliferation and ERK
Phosphorylation
(A) Thymocytes from normal littermate control (NLC) mice (circles)
PD98059 was shown to inhibit the PMA-stimulated ap- or sem20 (SM) mice (square) were treated with varying concentra-
tions of PMA (filled symbols) or PMA and 17.5 mM PD98059 (openpearance of phospho-ERK2 inboth wild-type and sem20
symbols). Proliferation was measured after 3 days in culture by thethymocytes (Figure 5B).
incorporation [3H]thymidine.
(B) Thymocytes were incubated at 378C for 1 hr in the presence or
The Effect of Inhibiting ERK Activation absence of 30 mM PD98059 then for an additional 10 min in the
on Thymic Development presence or absence of 10 ng/mL PMA. Whole-cell lysates from 5 3
The requirement for ERK activation in T cell develop- 106 cells were immunoblotted with anti-ERK2 (C-14).
ment was examined by adding PD98059 to FTOCs from
either E14 or E16 fetal mice. E14 thymi are composed and this is seen both in the percentage of cells gated
entirely of early, progenitor DN cells, whereas E16 thymi for CD41CD81 expression and in the percentage of cells
have a population of cells that have already differenti- that expressed a characteristic intermediate level of
ated into DP thymocytes and have many fewer DN pre- CD3. Considering the decrease in overall recovery, the
cursors. Organs were cultured for 5 days in the presence absolute number of DPs in PD98059-treated organ cul-
and absence of 30 mM PD98059, and the subsets pre- tures was therefore less than 20% that of controls. The
sent at the end of culture were analyzed by flow cy- inhibition of differentiation from DN to DP is thus not
tometry. complete, but it is consistent with the magnitude of
Since differentiation from E14 includes the prolifera- the effect of PD98059 on the proliferation of antigen-
tion step in thymic development, cell recoveries are activated T cells.
highly dependent on the extent of expansion. For the In the wild-type cultures there were very few mature
E14 FTOCs, the average cellular recovery in the pres- SPs, presumably reflecting the fact that the cells from
ence of PD98059 was 37% that of untreated cultures 5-day E14 FTOCs have only just completed differentia-
(Figure 6), implying that expansion of thymocytes de- tion. Surprisingly, there was a largepopulation of CD8SP
pends in part on ERK activation. The possibility also cells in E14 cultures treated with PD98059, and 60% of
exists that ERK is necessary for survival and that the these cells expressed high levels of CD3. Further analy-
decrease in cellularity is the result of accelerated sis of these CD3 high cells has shown that a large num-
apoptosis. Since this drop in cellularity was not seen in ber of the CD8SP cells expressed low levels of heat-
E16 cultures (Figure 7), the requirement for survival stable antigen (data not shown), an indication that the
would have to be specific for the DN-to-DP transition. cells are mature, antigen-responsive T cells (Ramsdell
In addition, there was no obvious decrease in cell viabil- et al.,1991). Since this population was not seen in exper-
ity in FTOCs from sem20 mice at the end of culture; iments initiated with E16 thymi (see below), we conclude
however, this issue is under further investigation. that inhibition of ERK activation before the differentia-
The flow cytometry profile of a representative E14 tion step to DP thymocytes dramatically promotes
FTOC is depicted in Figure 6. In untreated cultures the CD8SP thymocytes. Within the CD4SP population from
resulting cells are mainly DPs (81.8%). In cultures with wild-type mice there was a small but significant popula-
30 mM PD98059, the percentage of cells in the DP subset tion of CD3hi cells that was missing in cultures containing
PD98059.was reduced to slightly greater than 50% of controls,
Immunity
614
Figure 6. ERK Is Not Required for Transition to CD8 SP
E14 thymi were cultured for 5 days in the presence or absence of
Figure 7. ERK Is Required for Maturation from DP to CD4 SP30 mM PD98059 MEK inhibitor. Thymocytes were triple stained with
E16 thymi were cultured for 5 days in the presence or absence ofanti-CD4-PE, anti-CD8-Tricolor, and anti-CD3-FITC. Numbers rep-
30 mM PD98059 MEK inhibitor. Thymocytes were triple stained withresent the percentage of live cells in the indicated quadrant. Histo-
anti-CD4-PE, anti-CD8-Tricolor, and anti-CD3-FITC. Numbers rep-grams represent CD3 expression of total or SP thymocytes. Dashed
resent the percentage of live cells in the indicated quadrant. Histo-lines, thymi cultured in medium alone; solid lines, thymi cultured
grams represent CD3 expression of total or SP thymocytes. Dashedwith 30 mM PD98059. The average cell recovery (3 1025) was 6.7 6
lines, thymi cultured in medium alone; solid lines, thymi cultured0.6 for controls (n 5 7) and 3.5 6 2.2 for PD98059-treated cultures
with 30 mM PD98059. The average cell recovery (3 1025) was 6.4 6(n 5 6).
3.7 for controls (n 5 5) and 11.1 6 3.5 for PD98059-treated cultures
(n 5 7).
The thymi from E16 mice begin with a large population
of DPs, no SPs, and many fewer DN precursors com-
The Effect of ERK Activation on Early Expansionpared to E14 thymi (data not shown). These cultures
and Transition of Thymocytes from DN to DPprovide a way to examine the selection step and the
To analyze the effects of the inhibition of ERK activation,transition from DP to SP in the absence of effects on
we carried out experiments in which E14 thymus lobesthe early expansion in the DN-to-DP transition. Of note,
were cultured in the presence and absence of a MEKwe saw enhanced cellular recovery in cultures treated
inhibitor, PD98059. All of thecells in these cultures beginwith PD98059, but whether this reflects increased sur-
as early DN thymocytes, and so we can examine thevival or expansion is not yet known (Figure 7). We also
expansion and differentiation of thymocytes from DNfound a diminished number of mature thymocytes, a
to DP. Here we found that inhibition of ERK activationfeature most easily seen by comparing the number of
partially inhibited the expansion and differentiation ofCD3hi cells (Figure 7). The important point is that in
DN to DP cells. Considering that 25 mM PD98059 wasthese cultures, we consistently found a reversal in the
sufficient to inhibit T cell proliferation and ERK phos-CD4:CD8 ratio caused by a diminishment in the propor-
phorylation only partially, and since drug availability intion of CD4SPs and an increase in the proportion of
organ cultures may be diminished compared to suspen-CD8s. This result substantiates the alteration in lineage
sion cultures, we interpret these data to support thecommitment seen in E16 FTOCs from sem20 mice.
notion that expansion and early differentiation are de-
pendent on ERK activation. This is consistent with theDiscussion
results of Crompton et al. (Crompton et al., 1996), in
which the expression of a dominant interfering form ofIn this report we used genetic and pharmacological
MEK by retroviral expression in FTOCs caused inhibitionmethods to show that ERK activation affects thymocyte
of expansion. It is also consistent with the studies ofselection and especially promotes commitment to the
Swat et al. (1996), in which an activated form of RasCD4 phenotype. We discuss the influence of ERK on
promoted expansion in the absence of TCR rearrange-early maturation and positive selection and comment
ments. In experiments using a combination of dominanton the possibility that both ERK and Notch play impor-
tant roles in lineage commitment. interfering forms of Ras and MEK, Alberola-Ila et al.
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(1996) did not see inhibition at this stage. These discrep- A combination of these two avenues of investigation
provides a consistent view of ERK as a control pointancies have not yet been resolved, although the pre-
dominance of evidence favors the idea that ERK activa- for thymocyte selection and as an arbiter of lineage
commitment.tion is involved in some aspects of survival, expansion,
and differentiation at this stage of T cell development. The maturation of CD4SP thymocytes in AND-H-2d
mice was not entirely predictable. As stated above, ex-
pression of Ad and Ed is not compatible with the differen-
The Effect of ERK Activation on Positive tiation of AND thymocytes (Lerner et al., 1996). The cells
Selection and Lineage Commitment that do manage to differentiate have reduced levels of
In sem20 mice there was a statistically significant in- the transgenic Va11, resulting from the expression of a
crease in the percentage of cells that differentiated to second endogenous TCR a-chain. Nonetheless, pre-
be CD4SP thymocytes. This was supported by the ob- sumably there is still a TCR-mediated selection that was
servation that the CD4SP subset was enhanced in not apparently influenced by ERKsem. Whether this re-
AND 3 sem20-H-2b mice, in which the entire population flects the timing of selection or other influences of this
of thymocytes was subjected to positive selection. Al- genetic cross is not yet understood.
though ERK activation may have an overall effect on
positive selection, this analysis with a gain-of-function
hypersensitive form of ERK2 shows that ERK activation A Quantitative Instructional Mechanism for
Lineage Commitment: ERK and Notchselectively promotes CD4SP maturation. We argue that
this is actually an imbalance in the proportion of CD4 Previous studies have provided evidence that lineage
commitment can be explained in part by the magnitudeand CD8 T cells, based on four other observations. First,
there was a highly significant decrease in the number of the signal received. In the one study, replacement of
the CD8 cytoplasmic tail with that of CD4 caused theand percentage of CD8 T cells in the lymph nodes of
adult sem20 mice. Second, there was an increase in selection of thymocytes bearing an MHC class I±specific
transgenic TCR to differentiate into CD4SPs (Itano etCD4SP cells and a decrease in CD8SP cells in E16
FTOCs from sem20 mice. This is more representative al., 1996). The cytoplasmic tail of CD4 is known to bind
p56 lck more avidly than the cytoplasmic tail of CD8, andof the rate of maturation since it reflects the first wave
of differentiated cells, and presumably it is influenced thus these cells were thought to get an abnormally
strong coreceptor signal. Conversely, AND TCR trans-less by homeostatic mechanisms. Third, in E14 FTOCs
treatedwith PD98059, there appeared a largepopulation genic thymocytes that expressed an MHC class II±
specific TCR became CD8SPs in the absence of CD4of CD8SP CD3hi thymocytes, whereas the population of
CD4SP CD3hi thymocytes was undetectable. Fourth, in (Matechak et al., 1996). In this case, the absence of a
coreceptor signal changed the lineage from CD4 to CD8.E16 FTOCs treated with PD98059 there was again an
decrease in the proportion of CD4SP thymocytes and Both of these studies were interpreted to indicate that
ªstrengthº of the signal determined the lineage, and thean increase in the proportion of CD8SP thymocytes.
Using both genetic and pharmacological devices, we strength was determined by signaling through the core-
ceptor and through the TCR.conclude that positive selection and lineage commit-
ment are regulated at least in part by activation of ERK2. To understand the mechanisms involved in fate deter-
mination it is useful to turn to developmental processesIn the work cited above,Alberola-Ila et al. (1996) showed
that dominant interfering forms of Ras or MEK and espe- in simple organisms. There is a compelling analogy be-
tween T cell differentiation and that described for thecially the combination can inhibit positive selection and
the differentiation of DPs to SPs. Although they did not adoption of primary, secondary, and tertiary fates in
vulva development in C. elegans. In normal wild-typenote an effect on lineage commitment, in their data from
mice with a catalytically inactive form of MEK-1, the development, three cells receive an ªinductive signalº
from the anchor cell, and these three cells adopt theratio of CD4 to CD8 cells in adult thymi appeared to
depend partly on the level of MEK±dominant negative primary or secondary phenotypes of vulva cells. Genetic
screens for abnormal vulval development (Ferguson etexpression (Alberola-Ila et al., 1995). In the latter study
it is possible that the interfering form of MEK expressed al., 1987) identified a series of mutants that were ordered
through epistasis into a growth factor±activated (LIN-3)was relatively ineffective in the inhibition of the ERK
activation, a possibility consistent with its lack of effect (Hill and Sternberg, 1992), receptor tyrosine kinase (RTK)
(LET-23) (Aroian et al., 1990) pathway leading to ERKon T cell proliferation. The interfering form of Ras cer-
tainly affected several downstream pathways, so the (SUR-1, MPK-1) activation (Lackner et al., 1994). Consti-
tutive or enhanced activation along this canonical Ras-effects of p21H-rasN17 may be pleiotropic and more
difficult to interpret. In the present studies we used two mediated pathway (Han and Sternberg, 1990) results
in more than three vulval precursor cells (primary orentirely different ways of altering theamount of activated
ERK. While PD98059 may have effects beyond the inhi- secondary fates) characterized as Multivulva, whereas
diminished signaling within this pathway results in fewerbition of MEK, we propose that the analysis of ERKsem,
an inducible, hypersensitive mutant expressed at a low than three vulval precursor cells, that is, a greater num-
ber of cells that adopt the tertiary epithelial cell fate andlevel, is a particularly incisive means of analyzing the
role of ERK2 in T cell development. As mentioned above, a Vulvaless phenotype (Sundaram and Han, 1996). The
adoption of a secondary cell fate by the outer two cells,rlsem affects some but not all developmental processes
mediated by the EGF receptor, implying that ERKsem P5.p and P7.p, requires a ªlateralº signal through LIN-12
(analogous to Drosophila Notch) (Artavanis-Tsakonas etshows specificity for particular differentiation events.
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al., 1995). Cells that do not get either of these signals late DN cells that have completed TCR b-chain re-
arrangements may adopt the CD8 ab phenotype per-adopt the tertiary fate of epithelia. Studies of LIN-3 over-
expression suggest that the activation of the MAPK haps without a transition through the DP phenotype.
This may be analogous to an experiment in C. eleganspathway causes supernumerary vulva cells with the pri-
mary fate and prevents adoption of the secondary fate in which the level of LIN-12 can be titrated such that
the absence of an inductive (anchor) cell causes the(Katz et al., 1995). On the other hand, a hypermorphic
gain-of-function mutation in Lin-12 causes all six cells P6.p cell to adopt a secondary phenotype, whereas the
presence of an anchor signal causes the P6.p cell toto adopt a secondary fate (Greenwald and Seydoux,
1990). In addition, mosaic studies in which the P5.p and adopt a primary phenotype (Sternberg and Horvitz,
1989).P7.p cells have a let-23 deficiency show that these cells
can adopt the secondary fate in the absence of LET-23 As implied by Robey et al. (1996), we propose that
the CD4 lineage should be referred to as the primarysignaling (Koga and Ohshima, 1995). Thus, the adoption
of a primary, secondary, or tertiary fate depends on the cell fate and the CD8 lineage the secondary cell fate.
What we think of as the process of positive selectionamount and perhaps the timing of signaling through
the MAPK and Notch pathways (Sternberg and Horvitz, results from the inductive signal, and lineage specifica-
tion may depend on a signal through Notch-1 and on1989). Differentiation depends on an initial MAPK signal,
whereas lineage specification depends on the strength the strength and timing of the inductive signal. These
concepts definitely suggest a quantitative instructiveof the MAPK signal and the presence of a Notch signal.
Similarly, the Notch (Artavanis-Tsakonas et al., 1995) mechanism for lineage commitment, although how the
MAPK and Notch pathways are differentially activatedand the MAPK pathways (Chang et al., 1994) control
many aspects of Drosophila development, including ret- by theTCR, CD4, and CD8 coreceptors remains todeter-
mined. Within this instructional mechanism of fatedeter-inal differentiation. For example, the cell fate specifica-
tion of the R7 cell requires signaling through the sev- mination, there could be a stochastic component. This
would originate from the probability that a thymocyteenless-encoded receptor tyrosine kinase and activation
through Ras and the MAPK pathway (Hafen et al., 1994; receives a strong signal early in development in order
to activate ERK and down-regulate Notch. With timeZipursky and Rubin, 1994; Wassarman et al., 1995).
Notch expression can modify this fatespecification such and the absence of sufficient ERK activation, Notch may
initiate a positive feedback loop that results in differenti-that expression of an activated form of Notch under
control of the sevenless promoter (sev-Nact) gives rise ation toward the CD8 phenotype; this differentiation
would continue if the TCR is class I specific but wouldto a rough-eye phenotype, a phenotype similar to the
weak activation of the MAPK pathway (Fortini et al., abort for a lack of coreceptor signaling if the TCR is
class II specific. The extensive genetic analyses already1993). The concept for both vulva development in C.
elegans and retinal development in Drosophila is that carried out in Drosophila and C. elegans provide many
opportunities for further elaboration of these pathwaysthe balance of MAPK (inductive) and Notch (lateral) acti-
vation is important in primary versus secondary fate in T cell development.
specification.
Recent compelling studies by Robey et al. (1996) pro- Experimental Procedures
vide evidence that Notch can also function to direct
Micelineage commitment in thymocytes (Robey et al., 1996).
Mice were generated, bred, and maintained at the University ofThe transgenic expression of an activated, intracellular
California, San Diego animal facilities. Timed matings were set upform of Notch during T cell development favored the
by placing one male in a cage with two females for 16 hr. The day
formation of CD8 T cells over CD4 T cells. Thus, there after the male was removed was considered day 1 of gestation.
is a striking similarity between the lineage specification AND mice are transgenic for TCR a- and b-chains that confer speci-
in T cell development and the basic principles of fate ficity for PCC as described (Kaye et al., 1989, 1992).
specification worked out using classic genetics. The
experiments presented here show that ERK is required Generation of Transgenic Mice
for differentiation to the CD4 lineage and that the pEFD319NErk2 (Bott et al., 1994) was cut with NcoI and SpeI. Ends
were filled using Klenow. This was ligated into pTEX that had beenstrength of the signaldetermines thenumber of cells that
linerized with XhoI, blunted with Klenow, and treated with calf intesti-adopt the primary fate versus the second fate. Based on
nal phosphatase. The resulting plasmid was cut with KpnI and SalIthe work of Robey et al. (1996), this selection may be
to liberate the sevenmaker transgene and purified over a sucrose
modified by the presence of a strong signal through gradient. This was injected into C57BL/6J 3 BALB/c F1 single-cell
Notch. In thymus subsets, Notch is expressed at highest embryos at a concentration of 2 mg/ml. Founders were backcrossed
levels inDN thymocytes, lowest levels in DP thymocytes, to C57BL/6J.
and intermediate levels in SP thymocytes (Hasserjian et
al., 1996). A possibility is that ERK activation may down- Flow Cytometry and Antibodies
regulate the expression of Notch on developing DN thy- One million cells were washed in phosphate-buffered saline con-
taining 2% fetal calf serum and 0.1% sodium azide and stainedmocytes and thus interrupt Notch signaling. A weaker
using anti-CD4-phycoerythrin (PE) (Caltag) and anti-CD8-TRI-signal through the TCR or the coreceptor may be suffi-
COLOR (Caltag) and anti-CD3-fluorescein isothiocyanate (FITC)cient for differentiation but insufficient to down-regulate
(Pharmingen). Events were collected prior to analysis on a FACScan
Notch. This notion is consistent our observation that (Becton-Dickinson). Collection and analysis were performed using
inhibition of MEK during the DN-to-DP transition results CellQuest software (Becton-Dickinson). New analysis gates were
in large CD8SP CD3hi population in part consisting of generated with each experiment to compensate for changes in for-
ward scatter or side scatter as well as antibody staining intensity.ab T cells (Figure 6). In the presence of the MEK inhibitor,
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Western Analysis directly activates transcription of enhancer of split complex genes
in response to Notch receptor activity. Genes Dev. 9, 2609±2622.Cells were lysed in Triton X-100 lysis buffer (0.5% Triton X-100, 10
mM Tris [pH 8.0], 150 mM NaCl, 200 mM sodium vanadate, 1 mg/mL Berg, L.J.,Pullen, A.M., Fazekas de St. Groth, B., Mathis, D., Benoist,
aprotinin, 1 mg/mL leupeptin, 1 mM phenylmethylsulfonyl fluoride). C., and Davis, M.M. (1989). Antigen/MHC-specific T cells are prefer-
Next, 5 3 106 cell equivalents or 20 mg total cell lysate were sepa- entially exported from the thymus in the presence of their MHC
rated by 12% SDS-PAGE and transferred to Protran membrane ligand. Cell 58, 1035±1046.
(Schleicher and Schuell). Membrane was blocked in TBST (Tris- Bott, C.M., Thorneycroft, S.G., and Marshall, C.J. (1994). The sev-
buffered saline, 0.1% Tween-20) with 5% nonfat milk and incubated enmaker gain-of-function mutation in p42 MAP kinase leads to en-
with anti-ERK2 (C-14, Santa Cruz Biochem) or anti-phospho-MAPK hanced signalling and reduced sensitivity to dual specificity phos-
(New England Biolabs) in TBST, 5% milk. Blots were then incubated phatase action. FEBS Lett. 352, 201±205.
with goat anti-rabbit-horseradish peroxidase (Southern Biotechnol-
Brunner, D., Oellers, N., Szabad, J., Biggs, W.H.R., Zipursky, S.L.,ogy Associates) secondary antibody and developed using enhanced
and Hafen, E. (1994). A gain-of-function mutation in Drosophila MAPchemiluminescence (Amersham).
kinase activates multiple receptor tyrosine kinase signaling path-
ways. Cell 76, 875±888.
Fetal Thymic Organ Culture
Chan, S.H., Benoist, C., and Mathis, D. (1994a). In favor of the selec-Thymic lobes were harvested on E14 or E16 and placed on Transwell
tive model of positive selection. Semin. Immunol. 6, 241±248.filters (Costar). Thymi were cultured in Iscove's modified Dulbecco's
Chan, S.H., Waltzinger, C., Baron, A., Benoist, C., and Mathis, D.medium (supplemented with 10% fetal calf serum, glutamine, and
(1994b). Role of coreceptors in positive selection and lineage com-antibiotics) with or without 30 mM PD98059 (New England Biolabs)
mitment. EMBO J. 13, 4482±4489.at 378C, 5% CO2 for 5 days. Medium was replaced every 24 hr.
Lobes were strained through nylon mesh to release thymocytes. Chang, H.C., Karim, F.D., O'Neill, E.M., Rebay, I., Solomon, N.M.,
Viable cells were counted by propidium iodide exclusion. Therrien, M., Wassarman, D.A., Wolff, T., and Rubin, G.M. (1994).
Ras signal transduction pathway in Drosophila eye development.
Cold Spring Harbor Symp. Quant. Biol. 59, 147±153.Proliferation Assays
CD41 lymph node cells were obtained by complement-killing total Crompton, T., Gilmour, K.C., and Owen, M.J. (1996). The MAP kinase
lymph node cells using 3.168 (anti-CD8) and low-toxicity rabbit com- pathway controls differentiation from double-negative to double-
plement (Cedarlane). Lymph node cells were added at 5 3 104 per positive thymocyte. Cell 86, 243±251.
well in EHAA medium (Gibco±BRL) supplemented with 10% fetal Davis, C.B., and Littman, D.R. (1994). Thymocyte lineage commit-
calf serum. Total thymocytes were added at 4 3 105 per well in ment: is it instructed or stochastic? Curr. Opin. Immunol. 6, 266±272.
EHAA. In experiments in which anti-CD3 was added, indicated con-
Davis, C.B., Killeen, N., Crooks, M.E., Raulet, D., and Littman, D.R.
centrations of purified 145±2C11 were bound to plates pretreated
(1993). Evidence for a stochastic mechanism in the differentiation
with 10 mg/mL goat anti-hamster antibody (Southern Biotechnology of mature subsets of T lymphocytes. Cell 73, 237±247.
Associates). Assays were pulsed with 1 mCi [3H]thymidine (New
Dudley, E.C., Petrie, H.T., Shah, L.M., Owen, M.J., and Hayday, A.C.England Nuclear) for the final 8±12 hr of culture.
(1994). T cell receptor beta chain gene rearrangement and selectionAND TCR transgenic lymph node cells were collected and added
during thymocyte development in adult mice. Immunity 1, 83±93.at 2 3 104 cells/well in complete EHAA. After depletion of erythro-
Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J., and Saltiel, A.R.cytes, mitomycin C±treated splenocytes from B10.A mice were
(1995). A synthetic inhibitor of the mitogen-activated protein kinaseadded to culture at 5 3 105 cells/well as a source of antigen-pre-
cascade. Proc. Natl. Acad. Sci. USA 92, 7686±7689.senting cells. PCC peptide 88±104 was added at the indicated final
Ferguson, E.L., Sternberg, P.W., and Horvitz, H.R. (1987). A geneticconcentrations. Assays were pulsed with 1 mCi [3H]thymidine for
pathway for the specification of the vulval cell lineages of Caenor-the final 8±12 hr of culture. In experiments containing MEK inhibitor,
habditis elegans. Nature 326, 259±267.PD98059 (New England Biolabs) was added at 25 mM or the indi-
cated concentration. Fortini, M.E., Rebay, I., Caron, L.A., and Artavanis-Tsakonas, S.
(1993). An activated Notch receptor blocks cell-fate commitment in
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